Cargando…
Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2
AIM: To characterize the antigen on HepG2 cell that is specifically recognized by a new monoclonal antibody raised against human liver heparan sulfate proteoglycan (HSPG), clone 1E4-1D9. METHODS: The antigen recognized by mAb 1E4-1D9 was immunoprecipitated and its amino acid sequence was analyzed LC...
Autores principales: | Vongchan, Preeyanat, Linhardt, Robert J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340992/ https://www.ncbi.nlm.nih.gov/pubmed/28321273 http://dx.doi.org/10.4254/wjh.v9.i7.368 |
Ejemplares similares
-
mRNA transcriptome profiling of human hepatocellular carcinoma cells HepG2 treated with Catharanthus roseus-silver nanoparticles
por: Azhar, Nur Asna, et al.
Publicado: (2023) -
MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells
por: Zheng, Shun-Zhen, et al.
Publicado: (2019) -
Palmitate induces fat accumulation by activating C/EBPβ-mediated G0S2 expression in HepG2 cells
por: Zhao, Nai-Qian, et al.
Publicado: (2017) -
Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells
por: Lu, Cai-Jie, et al.
Publicado: (2017) -
Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism
por: He, Miao, et al.
Publicado: (2020)